An Overview of Experimental and Clinical Spinal Cord Findings in Alzheimer’s Disease
AbstractAlzheimer’s disease (AD) is a neurodegenerative disorder that occurs mainly in the elderly and presenile life stages. It is estimated that by the year 2050, 135 million people will be affected by AD worldwide, representing a huge burden to society. The pathological hallmarks of AD mainly include intracellular neurofibrillary tangles (NFTs) caused by hyperphosphorylation of tau protein, formation of extracellular amyloid plaques, and massive neural cell death in the affected nervous system. The pathogenesis of AD is very complicated, and recent scientific research on AD is mainly concentrated on the cortex and hippocampus. Although the spinal cord is a pivotal part of the central nervous system, there are a limited number of studies focusing on the spinal cord. As an extension of the brain, the spinal cord functions as the bridge between the brain and various parts of the body. However, pathological changes in the spinal cord in AD have not been comprehensively and systematically studied at present. We here review the existing progress on the pathological features of AD in the spinal cord. View Full-Text
Share & Cite This Article
Xie, Q.; Zhao, W.-J.; Ou, G.-Y.; Xue, W.-K. An Overview of Experimental and Clinical Spinal Cord Findings in Alzheimer’s Disease. Brain Sci. 2019, 9, 168.
Xie Q, Zhao W-J, Ou G-Y, Xue W-K. An Overview of Experimental and Clinical Spinal Cord Findings in Alzheimer’s Disease. Brain Sciences. 2019; 9(7):168.Chicago/Turabian Style
Xie, Qing; Zhao, Wei-Jiang; Ou, Guan-Yong; Xue, Wei-Kang. 2019. "An Overview of Experimental and Clinical Spinal Cord Findings in Alzheimer’s Disease." Brain Sci. 9, no. 7: 168.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.